Skip to main content
Log in

A rare cause of steroid-resistant nephrotic syndrome in a child: Answers

  • Clinical Quiz
  • Published:
Pediatric Nephrology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Niadeut P (2018) Etiology, clinical manifestations, and diagnosis of nephrotic syndrome in children. UpToDate. https://www.uptodate.com/contents/etiology-clinical-manifestations-and-diagnosis-of-nephrotic-syndrome-in-children. Accessed 21 Nov 2018

  2. Gipson DS, Massengill SF, Yao L, Nagaraj S, Smoyer WE, Mahan JD, Wigfall D, Miles P, Powell L, Lin JJ, Trachtman H, Greenbaum LA (2009) Management of childhood onset nephrotic syndrome. Pediatrics 124:747–757

    Article  Google Scholar 

  3. Niaudet P, Boyer O (2016) Idiopathic nephrotic syndrome in children: clinical aspects. In: Avner ED et al (eds) Pediatric Nephrology, 7th edn. Springer-Verlag, Berlin, pp 840–869

    Google Scholar 

  4. Van der Hilst JC, Bodar EJ, Barron KS, Frenkel J, Drenth JP, van der Meer JW, Simon A, International HIDS Study Group (2008)Long-term follow-up, clinical features, and quality of life in a series of 103 patients with hyperimmunoglobulinemia D syndrome. Medicine (Baltimore) 87:301–310

    Article  Google Scholar 

  5. Drenth JP, Cuisset L, Grateau G, Vasseur C, van de Velde-Visser SD, de Jong JG, Beckmann JS, van der Meer JW, Delpech M (1999) Mutations in the gene encoding mevalonate kinase cause hyper-IgD and periodic fever syndrome. International Hyper-IgD Study Group. Nat Genet 22:178–181

    Article  CAS  Google Scholar 

  6. Ammouri W, Cuisset L, Rouaghe S, Rolland MO, Delpech M, Grateau G, Ravet N (2007) Diagnostic value of serum immunoglobulinaemia D level in patients with a clinical suspicion of hyper IgD syndrome. Rheumatology (Oxford) 46:1597–1600

    Article  CAS  Google Scholar 

  7. Shendi HM, Walsh D, Edgar JD (2012) Etanercept and anakinra can prolong febrile episodes in patients with hyperimmunoglobulin D and periodic fever syndrome. Rheumatol Int 32:249–251

    Article  Google Scholar 

  8. Klasen IS, Göertz JH, van de Wiel GA, Weemaes CM, van der Meer JW, Drenth JP (2001)Hyper-immunoglobulin A in the hyperimmunoglobulinemia D syndrome. Clin Diagn Lab Immunol 8:58–61

    CAS  PubMed  PubMed Central  Google Scholar 

  9. Bader-Meunier B, Florkin B, Sibilia J, Acquaviva C, Hachulla E, Grateau G, Richer O, Farber CM, Fischbach M, Hentgen V, Jego P, Laroche C, Neven B, Lequerré T, Mathian A, Pellier I, Touitou I, Rabier D, Prieur AM, Cuisset L, Quartier P, SOFREMIP (Société Francophone pour la Rhumatologie et les Maladies Inflammatoires en Pédiatrie), CRI (Club Rhumatismes et Inflammations) (2011) Mevalonate kinase deficiency: a survey of 50 patients. Pediatrics 128:152–159

    Article  Google Scholar 

  10. Simon A, Drewe E, van der Meer JW, Powell RJ, Kelley RI, Stalenhoef AF, Drenth JP (2004) Simvastatin treatment for inflammatory attacks of the hyperimmunoglobulinemia D and periodic fever syndrome. Clin Pharmacol Ther 75:476–483

    Article  CAS  Google Scholar 

  11. Drenth JP, Vonk AG, Simon A, Powell R, van der Meer JW (2001) Limited efficacy of thalidomide in the treatment of febrile attacks of the hyper-IgD and periodic fever syndrome: a randomized, double- blind, placebo-controlled trial. J Pharmacol Exp Ther 298:1221–1226

    CAS  PubMed  Google Scholar 

  12. Topaloğlu R, Ayaz NA, Waterham HR, Yüce A, Gumruk F, Sanal O (2008) Hyperimmunoglobulinemia D and periodic fever syndrome; treatment with etanercept and follow-up. Clin Rheumatol 27:1317–13120

    Article  Google Scholar 

  13. Simms RW, Prout MN, Cohen AS (1994) The epidemiology of AL and AA amyloidosis. Bailliere’s Clin Rheumatol 8:627–634

    Article  CAS  Google Scholar 

  14. Picken MM (2007) New insights into systemic amyloidosis: the importance of diagnosis of specific type. Curr Opin Nephrol Hypertens 16:196–203

    Article  Google Scholar 

  15. Drenth JP, Haagsma CJ, van der Meer JW (1994) Hyperimmunoglobulinemia D and periodic fever syndrome: the clinical spectrum in a series of 50 patients. International Hyper-IgD Study Group. Medicine 73:133–144

    Article  CAS  Google Scholar 

  16. Simon A, Kremer HP, Wevers RA, Scheffer H, De Jong JG, Van Der Meer JW, Drenth JP (2004) Mevalonate kinase deficiency: evidence for a phenotypic continuum. Neurology 62:994–997

    Article  CAS  Google Scholar 

  17. Joroen CH, van der Hilst JC, Frenkel J (2010) Hyperimmunoglobulin D syndrome in childhood. Curr Rheumatol Rep 12:101–107

    Article  Google Scholar 

  18. Padeh YC, Rubinstein A (2018) Hyperimmunoglobuline D syndrome: pathophysiology. UpToDate. https://www.uptodate.com/contents/hyperimmunoglobulin-d-syndrome-pathophysiology. Accessed 16 Jan 2018

  19. Kostjukovits S, Kalliokoski L, Antila K, Korppi M (2015) Treatment of hyperimmunoglobulinemia D syndrome with biologics in children: review of the literature and Finnish experience. Eur J Pediatr 174:707–714

    Article  Google Scholar 

  20. Musters A, Tak PP, Baeten DL, Tas SW (2015)Anti-interleukin 6 receptor therapy for hyper-IgD syndrome. BMJ Case Rep. https://doi.org/10.1136/bcr-2015-210513

  21. Mulders-Manders CM, Simon A (2015)Hyper-IgDsyndrome/mevalonate kinase deficiency: what is new? Semin Immunopathol 37:371–376

  22. Siewert R, Ferber J, Horstmann RD, Specker C, Heering PJ, Timmann C (2006) Hereditary periodic fever with systemic amyloidosis: is hyper-IgD syndrome really a benign disease? Am J Kidney Dis 48:41–45

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Yılmaz Tabel.

Ethics declarations

Informed consent statement

Informed consent was obtained from the parents of the patient.

Conflict of interest

The authors declare that they have no conflict of interest.

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

This refers to the article that can be found at https://doi.org/10.1007/s00467-019-04381-w.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Guliyeva, L., Tabel, Y., Düzova, A. et al. A rare cause of steroid-resistant nephrotic syndrome in a child: Answers. Pediatr Nephrol 35, 621–623 (2020). https://doi.org/10.1007/s00467-019-04385-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00467-019-04385-6

Keywords

Navigation